# An Efficacy Study of Pomalidomide in Patient With Multiple Myeloma in Routine Clinical Practice

> **NCT02902900** · — · COMPLETED · sponsor: **Celgene** · enrollment: 2504 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02902900
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04-01
- **Primary completion:** 2022-05-31
- **Final completion:** 2022-05-31
- **Target enrollment:** 2504 (ACTUAL)
- **Last updated:** 2022-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02902900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02902900, "An Efficacy Study of Pomalidomide in Patient With Multiple Myeloma in Routine Clinical Practice". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT02902900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*